A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]

Sponsor
New York University (Other)
Overall Status
Completed
CT.gov ID
NCT01013935
Collaborator
St. Luke's-Roosevelt Hospital Center (Other)
556
1
2
37
15

Study Details

Study Description

Brief Summary

The purpose of this study is to see if a computer counseling tool helps Spanish-speaking people living with HIV to have safer sex and to do well on their HIV medicines.

Condition or Disease Intervention/Treatment Phase
  • Other: CARE+ Spanish computer counseling session
  • Other: CARE+ Spanish brief computer risk assessment session
N/A

Detailed Description

Latinos are the fastest-growing group with some of the largest health disparities including HIV. Barriers including language are associated with lower antiretroviral therapy (ART) adherence seen among Latinos. There are no evidence-based interventions (randomized trials that significantly reduced viral load and HIV transmission risk to sexual partners - 'positive prevention') delivered in Spanish in routine clinical practice. Our computerized counseling tool (CARE+) in a phase III trial of English-speaking adults increased ART adherence and reduced viral load and condom use errors. We now propose a longitudinal effectiveness (phase IV) study to evaluate the impact of computerized counseling in audio-narrated Spanish in a busy urban HIV clinic. This 'CARE+ Spanish' proposal is responsive to 06-OD(OBSSR)-101, for new technologies to improve adherence in clinical practice. Aim 1: Adapt CARE+ Spanish for use during routine clinical visits by Spanish-speaking HIV clinic attendees using an expert panel to shorten content and add Spanish audio dialects; do usability testing (n≤8). Aim 2: Establish real-world utility of 'CARE+ Spanish'. Peer staff will recruit Spanish-speaking adults on ART who will be randomly assigned to intervention (Group A n=250) or risk-assessment control (B, n=250) for 0,3-,6-,9-month sessions; at 12-month session groups will switch to opposite arm (delayed intervention design). Linear and generalized linear mixed effects models will analyze impact on 30-day ART adherence, clinic visit adherence, HIV-1 viral load and sexual risks, and to assess whether any Group A changes are sustained at month 12, among an expected n=400 retained study participants (120 female, 280 male). Aim 3: Explore cultural acceptability of tool among clients and clinic providers. Conduct qualitative exit interviews with patients (n=75) to assess technology uptake factors, cultural/linguistic acceptability, and suggestions for ongoing use among older vs. younger, and US-born vs. foreign-born Latino groups. Conduct two focus groups with providers (n≤30) to assess perceived technology barriers/facilitators. Analysis will identify factors affecting acceptability, utilization, and impact. Technology tools like CARE+ present significant opportunities to bridge the health promotion delivery gap, especially if linguistically adapted for often-neglected groups such as Latinos (15% of the US population).

Study Design

Study Type:
Interventional
Actual Enrollment :
556 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]
Study Start Date :
Jun 1, 2010
Actual Primary Completion Date :
Jul 1, 2013
Actual Study Completion Date :
Jul 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Full CARE+ Spanish computer-counseling group

Other: CARE+ Spanish computer counseling session
The computer will ask patients questions about taking HIV medicine. The computer will also ask patients questions about sexual and substance use activities. The computer will let patients look at short videos on various HIV medicine and HIV risk reduction topics and will then help patients create a health plan. Patients will get an anonymous print out at the end of the session and can choose to share with health care provider. There are questions about depression, suicide, or domestic violence. If a patient's answers indicate that they may be depressed, suicidal, or currently in an abusive relationship, we will refer them to a health worker at the clinic. We will repeat the session every 3 months up to 12 months total.
Other Names:
  • CARE+
  • Active Comparator: Brief risk assessment study group only (control)

    Other: CARE+ Spanish brief computer risk assessment session
    The computer will ask patients questions about taking HIV medicine. The computer will also ask patients questions about sexual and substance use activities. We will repeat the session every 3 months up to 12 months total.
    Other Names:
  • CARE+
  • Outcome Measures

    Primary Outcome Measures

    1. ART adherence [Every 3 months up to 12 months]

    2. HIV-1 viral load [Every 3 months up to 12 months]

    3. Sexual risks [Every 3 months up to 12 months]

    4. Clinic visit adherence [Every 3 months up to 12 months]

    Secondary Outcome Measures

    1. Qualitative exit interviews with patients (n=75) to assess technology uptake factors, cultural/linguistic acceptability, and suggestions for ongoing use among older vs. younger, and US-born vs. foreign-born Latino groups [At end of study]

    2. Two focus groups with providers (n≤30) to assess perceived technology barriers/facilitators [End of the study]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Hispanic birth or ancestry

    • Speaks Spanish (mono- or multi-lingual)

    Exclusion Criteria:
    • Lack of fluency in Spanish

    • Thought disorder that precludes participation

    • Inability to give informed consent due to altered mentation at time of enrollment (e.g., visibly inebriated or high).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St. Luke's Roosevelt New York New York United States 10011

    Sponsors and Collaborators

    • New York University
    • St. Luke's-Roosevelt Hospital Center

    Investigators

    • Principal Investigator: Ann Kurth, PhD, NYU

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ann Kurth, Professor, New York University
    ClinicalTrials.gov Identifier:
    NCT01013935
    Other Study ID Numbers:
    • 1RC1MH088307
    First Posted:
    Nov 16, 2009
    Last Update Posted:
    Sep 28, 2018
    Last Verified:
    Sep 1, 2018
    Keywords provided by Ann Kurth, Professor, New York University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 28, 2018